What Researchers Did
The researchers searched medical databases and hyperbaric literature sources for randomized or pseudo-randomized trials that compared hyperbaric oxygen therapy (HBOT) with no HBOT or sham treatment in children and adults with necrotizing fasciitis.
What They Found
This Cochrane systematic review found no trials that met its inclusion criteria, so it could not show whether adding HBOT to standard care for necrotizing fasciitis helps or harms. The searches covered several major databases up to September 2014, along with hyperbaric textbooks, journals and conference proceedings. The authors said they failed to find clinical evidence to support or refute the effectiveness of HBOT for this condition. The abstract reports no results on death rates, complications or side effects.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The review could not draw any conclusion about HBOT for necrotizing fasciitis because it found no eligible randomized or pseudo-randomized trials, and its searches ended in September 2014.